AcuamarkDx is pleased to announce the addition of Tim Gordon and Chiara Gabbi, MD, PhD, to ourboard of directors. Their expertise in financial strategy and clinical research will help guide us as we advance our groundbreaking early cancer detection technology through clinical development and toward commercialization.
Mr. Gordon brings 40 years of experience in audit and financial advisory services at Ernst & Young, where he supported health and life sciences companies through IPOs, mergers and acquisitions, and other pivotal financial transitions. Dr. Gabbi is a distinguished physician-scientist with over 20 years of experience in clinical and translational medicine, specializing in cancer, personalized medicine, and genomics.
To learn more, please visit the official press release.
Contact us at
Acuamark Diagnostics, Inc.
101 Avenue Of the Americas, Fl 3, JLabs
New York, NY, 10013
USA
